Medical News

RSS

R&D of HIV treatments at crossroads

IP Overview HIV Therapy 2009” ( www.frinnov.fr/en/ip-overview/sciences-de-la-vie/hiv-therapy-2.html ) establishes a panorama of the patents claiming “HIV and AIDS treatments” and analyses the key and emerging thematic and the strategic positions of the actors involved in this sector. In order to fully analyze this field, the information coming from 6800 published patents and patent applications was aggregated.

4 Nov 2009

Report addressing the connection between student health and academic achievement unveiled

In an effort to ensure that student health plays a central role in California’s education reform agenda, the state’s largest private health foundation today unveiled the first report produced from a multi-year project addressing the connection between student health and academic achievement.

4 Nov 2009

Canada Health Infoway makes best use of its funds for EHR projects, says Auditor General

A report released today by the Auditor General of Canada confirms Canada Health Infoway (Infoway) has "accomplished much in the eight years since its creation."

4 Nov 2009

Study sheds light on the rise in childhood asthma in developed countries

A University of Adelaide study may have shed light on the rise in childhood asthma in developed countries like Australia in recent decades.

4 Nov 2009

IDF clinical guidelines emphasize the importance of periodontal health for people with diabetes

New clinical guidelines released by the International Diabetes Foundation (IDF) emphasize the importance of periodontal health for people with diabetes. Diabetes affects approximately 246 million people worldwide, and this number is only expected to increase. The IDF is an organization of 200 national diabetes associations from 160 countries.

4 Nov 2009

Findings may lead to new drug therapies to reduce breast cancer metastasis

Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer.

4 Nov 2009

Enobia Pharma initiates study of bone-targeted enzyme replacement therapy for hypophosphatasia

Enobia Pharma announced today the initiation of a Phase 2 clinical study of ENB-0040, a bone-targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six-month study will assess the safety, efficacy and pharmacokinetics of ENB-0040 in up to 12 children with HPP.

4 Nov 2009

Hispanics are more likely to report increase in stress levels than whites or blacks: APA survey

Stress has a greater impact on young people than parents believe and Hispanics are more likely than whites or blacks to report an increase in stress levels over the last year, according to a new national survey released today by the American Psychological Association (APA).

4 Nov 2009

Teva Pharmaceutical launches Fexofenadine HCl and Pseudoephedrine HCl tablets

Teva Pharmaceutical Industries Ltd. announced today the commercial launch of Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, the same as the sanofi-aventis U.S. allergy treatment Allegra-D® 12 Hour (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) Extended-Release Tablets. Teva's product is an alternative to the brand product, which had annual sales of approximately $293 million in the United States for the twelve months that ended June 30, 2009, based on IMS sales data.

4 Nov 2009

Study sheds new light on threats to coral reproduction

What's the point of setting up marine reserves to protect coral reefs from pollution, ship groundings and overfishing if climate change could cause far more damage? A study published this week in London in Proceedings of the Royal Society B provides the answer.

4 Nov 2009

Colorful fruits and vegetables help boost immunity system

Hoping to keep the flu at bay? A strong immune system helps. Enjoying the bounty of colorful fruits and vegetables available right now can be an important step toward supporting your family's immune system this cold/flu season.

4 Nov 2009

Program to address neuroscientific progress in pain management

On November 13, the Center for Neurotechnology Studies at the Potomac Institute for Policy Studies will present the lecture “From a Neuroscience of Pain to a Neuroethics of Care” by Prof. James Giordano, internationally known for his work on the neuroscience and neuroethics of pain.

4 Nov 2009

Tonsil cancer patients harbouring HPV16 can avoid chemotherapy

Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer ("tonsil cancer") harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the side effects of chemotherapy.

4 Nov 2009

Radiation treatment as effective and as safe in reducing the risk of prostate cancer from returning

A shorter, five-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears to be just as effective and as safe in reducing the risk of prostate cancer from returning as standard radiation therapy, yet is delivered in two-and-a-half weeks less time, according to interim results of a randomized study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

4 Nov 2009

Breastfeeding: ADA position paper details health benefits for both infants and mothers

The American Dietetic Association has released an updated position paper on breastfeeding that details health benefits for both infants and mothers and encourages promotion of breastfeeding whenever possible.

4 Nov 2009

Early-morning colonoscopies yield more polyps per patient than later screenings

The effectiveness of a screening colonoscopy may depend on the time of day it is performed. According to a new UCLA study, early-morning colonoscopies yielded more polyps per patient than later screenings, and fewer polyps were found hour by hour as the day progressed.

4 Nov 2009

H1N1 vaccine: Discussions and debates

You can't avoid H1N1 media coverage. It's front-page news on the web, the presses, the airways. Vaccine details, or lack of, are spurring discussion and debate. And a lot of people are in a quandary about whether or not to have the H1N1 shot based on their personal views and the information disseminated for public knowledge.

4 Nov 2009

House Democrats pick up some moderate votes for health bill

House Speaker Nancy Pelosi is picking up some centrist votes for the Democratic health care reform bill, though a leak of a list held by Majority Whip Rep. Jim Clyburn has led to difficulties counting votes on support for a more moderate public option.

4 Nov 2009

Advanced equipment targets radiation to specific areas in the brain

Radiation oncologists at Rush University Medical Center are intent on finding ways to avoid damage to the critically important hippocampus and limbic circuit of the brain when cranial radiation is required to treat existing or potential metastatic cancers.

4 Nov 2009

ASTI's 'Tell-a-Friend program' for solving sleep-related problems

Adaptive Sound Technologies, Inc. (ASTI) announced today that it will pay cash rewards to ASTI customers who refer friends that in turn buy an Ecotones or Ecotones Duet directly from ASTI. The new "Tell-a-Friend" program rewards customers for doing what they have been doing since the first Ecotones was introduced late last year: letting friends in on the secret to better sleep.

4 Nov 2009